Efung Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Efung Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 12, 2026	Yuewei Medical	$14.3M Series B	Efung Capital	Bohai Chuangfu
Nov 28, 2025	Rigen Biotech	$14.1M Series B	Efung Capital	—
Jun 5, 2025	QureBio	$14.0M Series C	Fan Rongkui	—
May 6, 2023	Lingyi Biology	$14.5M Series A	Efung Capital	Hongshan Capital Group (Sequoia Capital China)
Jan 18, 2023	IASO Biotherapeutics	$73.9M Series C	—	Hongcheng Investment, Housen Care Brothers, Nanjing Jiangbei New Area State-owned Asset Management, Shanghai Guoxin Investment & Development, Shanghai Waigaoqiao Free Trade Zone Group
Jun 9, 2022	Circular Code Biology	$20.0M Pre-Series A	K2 Venture Partners	Kaitai Capital
Jan 5, 2022	Atom Bioscience & Pharmaceutical	$45.0M Series C	Yuhang Teng, Huang Pu	Hongshan Capital Group (Sequoia Capital China), Kaitai Capital, Livzon Pharmaceutical Group, Unifortune Investment Holdings Group
Aug 28, 2021	Genuine Biotech	$100.0M Series B	Efung Capital	—
Jul 1, 2021	HighlightLL Pharma	$28.0M Series B	Efung Capital	Kaitai Capital
Mar 12, 2020	Harbour Biomed	$75.0M Series B	—	AdvanTech, GIC, Greater Bay Area Homeland Development Fund, JT New Century, Legend Capital, SK, Zhejiang University Future Capital
Oct 2, 2019	Elicio Therapeutics	$33.0M Series B	—	Livzon Pharmaceutical Group
Dec 3, 2018	Tactiva Therapeutics	$35.0M Series A	Panacea Healthcare Partners	VI Ventures
Jan 5, 2018	KBP Biosciences	$76.0M Series A	Benjamin Qiu, Jianping Tang	Fred Craves, Cash Capital, Elite Capital, GF Xinde Life Science Investment Fund, Korea Investment Partners, Ping An Ventures, Sangel Capital
Jan 1, 2018	Centrexion Therapeutics	$67.0M Series D	Sara Nayeem	Avoro Ventures, David Parkinson, Elliott Sigal, 6 Dimensions Capital, ArrowMark Partners, InterWest Partners, Stella Xu
Jan 9, 2017	Ascentage Pharma	$72.1M Series B	Future Industry Ventures	Hidragon Capital, KIP Capital, Oriza Ventures, Shiyu Capital, YuanMing Capital
Aug 15, 2015	Ascentage Pharma	$15.5M Series A	Oriza Ventures, YuanMing Capital	BioVentures Investors, Grains Valley Venture Capital